Oral composition for Anti-inflammation in aging tissues
An oral composition with specific compounds effectively suppresses inflammation-related factors in aging tissues by targeting senescent cells, addressing the inadequacies of existing technologies and meeting the demand for personalized anti-inflammatory solutions.
WO2026134296A1PCT designated stage Publication Date: 2026-06-25SUNSTAR INC
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- SUNSTAR INC
- Filing Date
- 2025-12-18
- Publication Date
- 2026-06-25
Smart Images
Figure JPOXMLDOC01-APPB-C000001 
Figure JPOXMLDOC01-APPB-C000002 
Figure JPOXMLDOC01-APPB-C000003
Abstract
The main purpose of the present inventors is to provide a technique for suppressing inflammation, in particular, in aging tissues within the oral cavity. The present inventors have found that an oral composition containing at least one selected from the group consisting of β-glycyrrhetinic acid, glycyrrhizic acid, ascorbic acid, tocopherol nicotinate, tocopherol acetate, pyridoxine, cobalamin, retinol, retinol acetate, riboflavin, phylloquinone, calciferol, anthraquinone, menaquinone-4, and L-aspartic acid, and chemically acceptable salts thereof, quercetin, genistein, fisetin, nobiletin, kaempferol, apigenin, and naringenin, and glycosides thereof, and methyl hesperidin can suppress inflammation, in particular, in aging tissues within the oral cavity.
Need to check novelty before this filing date? Find Prior Art